AI’s predictive capabilities are increasing and perhaps surpassing human intuition in predicting the outcomes of neuroscience ...
Novartis will partner with PTC Therapeutics to develop PTC’s PTC518 Huntington's disease program and an unspecified number of related molecules, through an up-to-$2.9 billion exclusive global license ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback